Guttmacher Institute

Mifepristone is safe, effective and widely accepted by providers and patients in the US. Yet it remains a prime target of the anti-abortion movement, including in the current politically motivated review at the FDA. A new analysis by Guttmacher experts Kelly Baden, Joerg Dreweke and Rachel Jones examines mifepristone’s exemplary safety record and escalating attacks rooted in junk science. Learn more: https://gu.tt/42VEcff #MedicationAbortion #ReproductiveHealth

Family planning is at risk globally. That’s why #ICFP2025 is more important than ever: a space to champion evidence-based action and safeguard sexual and reproductive health and rights. Connect with our researchers all week and don’t miss our side event on November 5th. 🔗 Guttmacher’s program: https://gu.tt/4737XvM 🔗 Side event registration: https://gu.tt/4owlSSi

Affordable access to person-centered reproductive health care—including contraception—is crucial to bodily autonomy for all. #ReproRights101

The evidence is clear: investing in sexual and reproductive health (SRH) services saves lives. Fully meeting core SRH needs could: - Reduce maternal mortality by 71% - Lower neonatal mortality by 62% - Decrease unsafe abortions by 70% This September, we highlighted this data across convenings at #UNGA80. As we marked a year-long reflection on 30 years since the Beijing Declaration, discussions underscored the urgent need for renewed global commitment—so that in the next 30 years, equality and sexual and reproductive rights are realized for all. #ReproRights #FeministFuture #SRHR

The US Department of Health and Human Services has reportedly laid off the staff at the Office of Population Affairs (OPA). This is a shocking move that has massive consequences for reproductive health care nationwide. These layoffs threaten Title X—the nation’s only federal family planning program—and the Teen Pregnancy Prevention (TPP) Program, which funds evidence-based sex education. Title X serves people with low incomes, those with no insurance or who are underinsured, young people, and immigrants. Title X helped 2.8 million people get birth control, STI testing, and pregnancy counseling in 2023. The TPP Program aims to build an evidence base for effective sex education programs. Ending this program would severely damage efforts focused on young people's sexual and reproductive health. Threats to these programs are not happening in isolation. Combined with cuts to Medicaid, the defunding of Planned Parenthood and continued attacks on abortion access, this administration is systematically dismantling SRH care in the US. The harm—particularly for people who are already marginalized by the health care system—is devastating. Learn more about the potential impact of undercutting OPA: https://gu.tt/40R1hip #ReproductiveHealth #ReproductiveRights

The latest Studies in Family Planning special issue examines how to make family planning measurement more person-centered, directly measuring people’s own contraceptive needs and preferences.   Guttmacher experts Elizabeth Sully, Octavia Mulhern, Rubina Hussain, Ann Moore and Jewel Gausman contributed across four papers and commentaries that advance this conversation, offering new ways to measure key family planning indicators that reflect people’s own reproductive preferences and needs. Together, their work pushes the field toward indicators that go beyond assuming increased modern contraceptive use as the only positive outcome, and instead center the bodily autonomy and rights of all people to achieve their own self-expressed sexual and reproductive health goals.   #SRHR #FamilyPlanning 

High-quality data and research are vital to shaping policies that defend and advance reproductive freedom.  Our new research roundup explores: - Young people’s access to reproductive health care in the US   - Telehealth services at publicly funded clinics - Barriers to preferred birth control methods, especially for LGBTQ patients - Impact of Medicaid expansion on contraceptive use in marginalized communities Share to put facts front and center.  #ReproductiveHealth #Research 

Family planning is under threat, despite its proven role in saving lives, improving health and fueling economic growth. That’s why, at #ICFP2025, we’re highlighting two evidence-driven initiatives. - Adding It Up continues to provide essential estimates on the need for, impact of and costs of sexual and reproductive health services. - We will also introduce the Family Planning Impact Consortium, a collaborative effort generating evidence on how investments in #familyplanning advances women’s empowerment and economic development. Join us as we showcase this important work. 🔗 Register now: https://gu.tt/4hbwrYB #FPimpact #AddingItUp #SRHR

All people should be able to make decisions about their lives and futures with dignity. #ReproductiveHealth #ReproductiveRights

We’re thrilled to be attending the 2025 International Conference on Family Planning from Nov 1–6 in Colombia! Our team will unveil new research and resources to advance global action for #SRHR. Stay tuned on our socials for exciting updates throughout the week and check out what we’ll be sharing at the conference: https://gu.tt/4737XvM #SRHR #ICFP2025